All Press Releases
PILA PHARMA ANNOUNCES NEW CHIEF FINANCIAL OFFICER (CFO)
Malmö, 13 December 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") today announces the appointment of Hampus Darrell as new CFO. Hampus Darrell is joining with an extensive professional accounting tenure, and he will provide financial and accounting expertise to PILA PHARMA, thus securing a continuous high standard of financial management and reporting. He graduated from Lund University,…
PILA PHARMA ANNOUNCES INITIATION OF STUDY IN PRECLINICAL RESEARCH COLLABORATION IN CARDIOVASCULAR DISEASE
Malmö, 21 November 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") today announces the initiation of the study associated to the co-sponsorship of the research collaboration with the Research Group of Professor Dick Wågsäter, Uppsala University, Sweden (the "Research Group"). The aim is to complete initial investigations on the effect of PILA PHARMA's lead molecule, XEN-D0501, on Abdominal Aorta…
PILA PHARMA INVITES TO NORDIC INVESTOR MEETINGS
Malmö, 20 November 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") (FN STO: PILA) hereby invites you to participate in these upcoming Nordic investor events: ___________AktieInfo Investor Evening (Aalborg, Denmark)Monday, 25 November 2024 from 17:00 CETAktieInfo Investor Evening (Kolding, Denmark)Tuesday, 26 November 2024 from 17:00 CET Aktiespararna 'Stora Aktiedagarna' (ONLINE / Stockholm, Sweden)Thursday, 28 November 2024 from 14:30 CET Redeye Technology…